Skip to main content
Equibles

Vipin Kumar Chaturvedi, Ph.D.

GRI Bio, Inc. (GRI)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Vipin Kumar Chaturvedi, Ph.D.

GRI Bio, Inc. reported in an 8-K filed April 21, 2023 that Vipin Kumar Chaturvedi, Ph.D. was appointed Chief Scientific Officer, effective April 21, 2023.

“the Board appointed W. Marc Hertz, Ph.D. as the Company's Chief Executive Officer (principal executive officer), Leanne Kelly as the Company's Chief Financial Officer (principal financial and accounting officer), Vipin Kumar Chaturvedi, Ph.D. as the Company's Chief Scientific Officer, and Albert Agro, Ph.D. as the Company's Chief Medical Officer, each effective as of the Closing and to hold office until his or her respective successor(s) shall have been duly elected and qualified or until his or her earlier resignation or removal.”
GRI Bio, Inc. Form 8-K, filed April 21, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at GRI Bio, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.